Literature DB >> 4027918

Ependymomas. Factors in clinical and diagnostic staging.

C R West, D A Bruce, P K Duffner.   

Abstract

In ependymoma, there is evidence that indicates that age, sex, histologic patterns, functional status, location, duration of symptoms, size, and accessibility to surgical removal influence survival. The role of neuron-specific enolase and other biologic markers must await the accumulation of further information. Further advances in diagnostic imaging, immunodiagnostics, and intraoperative staging should lead to a better understanding of the disease and pinpoint prognostic factors more precisely. A profile that contains important information is suggested; this should eventually lead to the development of a staging system.

Entities:  

Mesh:

Year:  1985        PMID: 4027918     DOI: 10.1002/1097-0142(19851001)56:7+<1812::aid-cncr2820561319>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

1.  Prognostic relevance of localization and grading in intracranial ependymomas of childhood.

Authors:  R I Ernestus; R Schröder; H Stützer; N Klug
Journal:  Childs Nerv Syst       Date:  1996-09       Impact factor: 1.475

2.  Fourth ventricle ependymomas. A study of 20 cases with survival analysis.

Authors:  L Ferrante; L Mastronardi; G Schettini; P Lunardi; A Fortuna
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

3.  Recurrent low-grade glioma in children with special reference to computed tomography findings and pathological changes.

Authors:  N Morota; K Sakamoto; N Kobayashi; K Hashimoto
Journal:  Childs Nerv Syst       Date:  1990-05       Impact factor: 1.475

4.  Histologic prognostic factors in ependymoma.

Authors:  D Schiffer; A Chiò; M T Giordana; A Migheli; L Palma; B Pollo; R Soffietti; A Tribolo
Journal:  Childs Nerv Syst       Date:  1991-08       Impact factor: 1.475

5.  A family with spinal anaplastic ependymoma: evidence of loss of chromosome 22q in tumor.

Authors:  Takashi Yokota; Takayuki Tachizawa; Koichi Fukino; Akira Teramoto; Jun Kouno; Koshi Matsumoto; Mitsuru Emi
Journal:  J Hum Genet       Date:  2003-10-18       Impact factor: 3.172

6.  Supratentorial ependymomas in childhood: clinicopathological findings and prognosis.

Authors:  R I Ernestus; O Wilcke; R Schröder
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 7.  Survival following treatment for intracranial ependymoma: a review.

Authors:  G Tamburrini; M D'Ercole; B L Pettorini; M Caldarelli; L Massimi; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2009-04-22       Impact factor: 1.475

8.  Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973-2005).

Authors:  Dayron Rodríguez; Michael C Cheung; Nadine Housri; Alfredo Quinones-Hinojosa; Kevin Camphausen; Leonidas G Koniaris
Journal:  J Surg Res       Date:  2009-05-14       Impact factor: 2.192

9.  Outcome of teenagers and young adults with ependymoma: the Royal Marsden experience.

Authors:  Lucas Moreno; Francisco Jose Bautista; Stergios Zacharoulis
Journal:  Childs Nerv Syst       Date:  2009-06-16       Impact factor: 1.475

10.  The history of ependymoma management.

Authors:  Kyu-Won Shim; Dong-Seok Kim; Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2009-05-21       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.